Endothelin-1 in human prostatic carcinoma treated with androgen withdrawal: An immunohistochemical study

Cancer

Volumn 91, Issue 10, 2001, Pages 1933-1939

  De Matteis, Anna ^a   Guidi, Alessandra ^b   Paolo, Barbara Di ^a   Franco, Giorgio ^c   Revoltella, Roberto P ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c CNR   (Italy)

Author keywords

Androgen withdrawal; Androgenic receptors; Endothelin 1; Prostatic carcinoma

Indexed keywords

ANDROGEN RECEPTOR; CYPROTERONE ACETATE; ENANTONE DEPOT; ENDOTHELIN 1; GOSERELIN; LEUPRORELIN;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; CYPROTERONE ACETATE; ENDOTHELIN-1; GOSERELIN; HUMANS; IMMUNOENZYME TECHNIQUES; LEUPROLIDE; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TREATMENT OUTCOME;

EID: 0035873684     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010515)91:10<1933::AID-CNCR1216>3.0.CO;2-Z     Document Type: Article

References (17)

1. Gene expression and autoradiographic localization of endothelin-1 and its receptors A and B in the different zones of the normal human prostate
2. Endothelin-1 in the human prostate: Tissue levels, source of production and isometric tension studies
3. Evaluation of the effect of endothelin-1 and characterization of the selective endothelin A receptor antagonist PD155080 in the prostate
4. Mitogenic activity of endothelin on human cultured prostatic smooth muscle cells
5. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate
6. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer
7. Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostate cancer
8. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
9. Upregulation of endothelin 1 and its precursor by IL-1beta, TNF-alpha, and TGF-beta in the PC3 human prostate cancer cell line
10. New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade
11. Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment
12. ET-1 expression and growth inhibition of prostate cancer cells: A retinoid target with novel specificity
13. Detection and epitope mapping of immunoreactive human endothelin-1 using ELISA and a surface plasmon resonance-based biosensor
14. Androgen receptors in endocrine-therapy-resistent human prostate cancer
15. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy
16. Distant metastases from prostatic carcinoma express androgen receptor protein
17. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping